G20210A Prothrombin Mutation and Critical Limb Ischaemia in Patients with Peripheral Arterial Disease

European Journal of Vascular and Endovascular Surgery

Volumn 38, Issue 1, 2009, Pages 113-117

  Sartori, M ^a   Favaretto, E ^a   Legnani, C ^a   Cini, M ^a   Conti, E ^a   Pili, C ^a   Palareti, G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Arterial thrombosis; G20210A prothrombin; Lower limb artery disease; Peripheral arterial disease; R506Q FV Leiden; Thrombophilic risk factor

Indexed keywords

ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BLOOD CLOTTING FACTOR 5; PROTEIN C; PROTEIN S; PROTHROMBIN;

AGE DETERMINATION; AGED; ARTERY DISEASE; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROL GROUP; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC MARKER; HUMAN; INHERITANCE; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SMOKING; STAGING; THROMBOCYTE AGGREGATION; THROMBOPHILIA;

AGED; DNA; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ISCHEMIA; LEG; MALE; MUTATION; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; PROTHROMBIN; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 67349171009     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.02.014     Document Type: Article

References (23)

1. Kannel W.B., and Shurtleff D. The natural history of arteriosclerosis obliterans. Cardiovasc Clin 3 (1971) 37-52
2. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
3. Aboyans V., Criqui M.H., Denenberg J.O., Knoke J.D., Ridker P.M., and Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 113 (2006) 2623-2629
4. McDermott M.M., Green D., Greenland P., Liu K., Criqui M.H., Chan C., et al. Relation of levels of hemostatic factors and inflammatory markers to the ankle brachial index. Am J Cardiol 92 (2003) 194-199
5. Kim R.J., and Becker R.C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146 (2003) 948-957
6. Gerdes V.E., ten Cate H., de Groot E., Kwa V.I., Prins M.H., Reitsma P.H., et al., Amsterdam Vascular Medicine Group. Arterial wall thickness and the risk of recurrent ischemic events in carriers of the prothrombin G20210A mutation with clinical manifestations of atherosclerosis. Atherosclerosis 163 (2002) 135-140
7. Santilli J.D., and Santilli S.M. Chronic critical limb ischemia: diagnosis, treatment and prognosis. Am Fam Physician 59 (1999) 1899-1908
8. 1999 World Health Organization-International Society of Hypertension. Guidelines for the management of hypertension. J Hypertens 17 (1999) 151-183
9. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 106 (2002) 3143-3421
10. Sartori M., Ceolotto G., Dorigatti F., Mos L., Santonastaso M., Bratti P., et al., HARVEST Group. RGS2 C1114G polymorphism and body weight gain in hypertensive patients. Metabolism 57 (2008) 421-427
11. Ebrahim S., Papacosta O., Whincup P., Wannamethee G., Walker M., Nicolaides A.N., et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 30 (1999) 841-850
12. Favaretto E., Pili C., Amato A., Conti E., Losinno F., Rossi C., et al. Analysis of agreement between Duplex ultrasound scanning and arteriography in patients with lower limb artery disease. J Cardiovasc Med 8 (2007) 337-341
13. Greenland P., Abrams J., Aurigemma G.P., Bond M.G., Clark L.T., Criqui M.H., et al. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: non-invasive tests of atherosclerotic burden. Writing Group III. Circulation 101 (2000) 16-22
14. Legnani C., Palareti G., Guazzaloca G., Cosmi B., Lunghi B., Bernardi F., et al. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use. Eur Heart J 23 (2002) 984-990
15. Purcell S., Cherny S.S., and Sham P.C. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
16. Reny J.L., Alhenc-Gelas M., Fontana P., Bissery A., Julia P.L., Fiessinger J.N., et al. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost 2 (2004) 1334-1340
17. Sofi F., Lari B., Rogolino A., Marcucci R., Pratesi G., Dorigo W., et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 41 (2005) 255-260
18. Cohn D.M., Roshani S., and Middeldorp S. Thrombophilia and venous thromboembolism: implications for testing. Semin Thromb Hemost 33 (2007) 573-581
19. Renner W., Köppel H., Brodmann M., Pabst E., Schallmoser K., Toplak H., et al. Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. Thromb Haemost 83 (2000) 20-22
20. Mueller T., Marschon R., Dieplinger B., Haidinger D., Gegenhuber A., Poelz W., et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz peripheral arterial disease (LIPAD) study. J Vasc Surg 41 (2005) 808-815
21. Abukishe A., Brandt M., Hedderich J., Hirt S., Lentz S., Schäfer H., et al. Mutation in factor II and factor V gene in patients with peripheral arterial occlusive disease. Hamostaseologie 26 (2006) 197-200
22. Franco R.F., Trip M.D., ten Cate H., van den Ende A., Prins M.H., Kastelein J.J., et al. The 20210 G→A mutation in the 3′-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 104 (1999) 50-54
23. Feinbloom D., and Bauer K.A. Assessment of hemostatic risk factors in predicting arterial thrombotic events. Arterioscler Thromb Vasc Biol 25 (2005) 2043-2053